company-logoNiagen Bioscience Inc$7.56
%
Analyst Rating: Hold

Stock Details

CEO

Robert N. Fried

Sector

Healthcare

Industry

Biotechnology

Full Time Employees

104

Address

10900 Wilshire Blvd, Suite 600, Los Angeles, CA, 90024

Niagen Bioscience Inc is a bioscience company dedicated to healthy aging. The Company leads research on nicotinamide adenine dinucleotide.

Top Competitors

Income Statement  

Financials

Selected Year

Revenue Estimates

EPS Estimates

Net Income Estimates

Price target for Niagen Bioscience Inc  $7.56

EPS

Revenue

Institutional Holder

Congress Tracker 

Insider Trading of Key Employees

Financial News: NAGE